GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation, Published online: 09 August 2023; doi:10.1038/s41409-023-02033-0GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 9, 2023 Category: Hematology Authors: Fran çois Dachy Sabine Furst Boris Calmels Thomas Pagliardini Samia Harbi Benjamin Bouchacourt Anne Calleja Claude Lemarie Aude Collignon Guillaume Morel Faezeh Legrand Elena Bekrieva Angela Granata Pierre Jean Weiller Christian Chabannon Jean Marc Schia Source Type: research
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, Published online: 08 August 2023; doi:10.1038/s41409-023-02075-4Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 8, 2023 Category: Hematology Authors: Jaime Sanz Myriam Labopin Thomas Pabst Jurjen Versluis Gwendolyn Van Gorkom Ellen Meijer Tobias Gedde-Dahl Juan Montoro William Arcese Jose Antonio P érez-Simón Nicolaas Schaap Johan Maertens Radovan Vrhovac Francesco Lanza Norbert Claude Gorin Mohamad Source Type: research
Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study
Bone Marrow Transplantation, Published online: 08 August 2023; doi:10.1038/s41409-023-02068-3Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 8, 2023 Category: Hematology Authors: Joseph P. McGuirk Leland Metheny III Luis Pineiro Mark Litzow Scott D. Rowley Batia Avni Roni Tamari Hillard M. Lazarus Jacob M. Rowe Michal Sheleg Daniel Rothenstein Nitsan Halevy Tsila Zuckerman Source Type: research
Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy
Bone Marrow Transplantation, Published online: 07 August 2023; doi:10.1038/s41409-023-02076-3Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 7, 2023 Category: Hematology Authors: Shigeo Fuji Akitoshi Hakoda Junya Kanda Takahiro Fukuda Noriko Doki Yuta Katayama Naoyuki Uchida Yukiyasu Ozawa Yoshinobu Kanda Masatsugu Tanaka Keisuke Kataoka Takahide Ara Masashi Sawa Makoto Onizuka Yasushi Onishi Takafumi Kimura Tatsuo Ichinohe Yoshik Source Type: research
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT
Bone Marrow Transplantation, Published online: 05 August 2023; doi:10.1038/s41409-023-02048-7Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 5, 2023 Category: Hematology Authors: R émi Tilmont Ibrahim Yakoub-Agha Diderik-Jan Eikema Nienke Zinger Mathias Haenel Nicolaas Schaap Concepcion Herrera Arroyo Christine Schuermans Britta Besemer Monika Engelhardt J ürgen Kuball Mariagrazia Michieli Natalie Schub Keith M. O. Wilson Jean H Source Type: research
Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)
Bone Marrow Transplantation, Published online: 04 August 2023; doi:10.1038/s41409-023-02079-0Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC) (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 4, 2023 Category: Hematology Authors: Marica Rossi Sarah Szepetowski Karima Yakouben Catherine Paillard Anne Sirvent Martin Castelle Charline Pegon Christophe Piguet Audrey Grain Marie Angoso Marie Robin Nathalie Dhedin Corinne Pondarr é C écile Dumesnil de Maricourt Ana Berceanu Pauline Si Source Type: research
Nutrition support and clinical outcomes following allogeneic stem cell transplantation
Bone Marrow Transplantation, Published online: 04 August 2023; doi:10.1038/s41409-023-02080-7Nutrition support and clinical outcomes following allogeneic stem cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 4, 2023 Category: Hematology Authors: Sarah Andersen Jiani Xu Stacey Llewellyn Glen Kennedy Judy Bauer Source Type: research
PET assessment of acute gastrointestinal graft versus host disease
Bone Marrow Transplantation, Published online: 03 August 2023; doi:10.1038/s41409-023-02038-9PET assessment of acute gastrointestinal graft versus host disease (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 3, 2023 Category: Hematology Authors: Ashleigh P. Scott Andrea Henden Glen A. Kennedy Siok-Keen Tey Source Type: research
Lung transplantation for pulmonary graft versus host disease: experience from a referral organ transplantation center
Bone Marrow Transplantation, Published online: 02 August 2023; doi:10.1038/s41409-023-02074-5Lung transplantation for pulmonary graft versus host disease: experience from a referral organ transplantation center (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 2, 2023 Category: Hematology Authors: Riad El Fakih Rayid Abdulqawi Amer Bugnah Tarek Ziad Arabi Walid Rasheed Loui Ezzat Marwan Shaheen Naeem Chaudhri Fahad Almohareb Eid A. Al-Mutairy Mahmoud Aljurf Source Type: research
Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy—a guidance by the GoCART Coalition Pharmacist Working Group
Bone Marrow Transplantation, Published online: 01 August 2023; doi:10.1038/s41409-023-02072-7Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy—a guidance by the GoCART Coalition Pharmacist Working Group (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - August 1, 2023 Category: Hematology Authors: Katerina Nezvalova-Henriksen Claudia Langebrake Tiene Bauters Maria-Estela Moreno-Martinez Emelie Ahnfelt Heidi Ekelund Vera Domingos Vera Pires Agnes Bonnin Ines Bojani ć Yolanda Cabrerizo Sofie Terwel Alice Tam Source Type: research
Safety and efficacy of immune checkpoint inhibitors after allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation, Published online: 29 July 2023; doi:10.1038/s41409-023-02073-6Safety and efficacy of immune checkpoint inhibitors after allogeneic hematopoietic cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - July 29, 2023 Category: Hematology Authors: Hanan Alkhaldi Mohamed Kharfan-Dabaja Riad El Fakih Mahmoud Aljurf Source Type: research
Treatment and outcome of second-line therapy for POEMS syndrome after autologous stem cell transplantation
Bone Marrow Transplantation, Published online: 24 July 2023; doi:10.1038/s41409-023-02047-8Treatment and outcome of second-line therapy for POEMS syndrome after autologous stem cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - July 24, 2023 Category: Hematology Authors: An-an Li Yan-ying Yu Xue-min Gao Hao Zhao Xin-xin Cao Lu Zhang Dao-bin Zhou Jian Li Source Type: research
Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience
Bone Marrow Transplantation, Published online: 21 July 2023; doi:10.1038/s41409-023-02035-yTrends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - July 21, 2023 Category: Hematology Authors: Farah Yassine Mohamed A. Kharfan-Dabaja Athanasios Tsalantsanis Vivek Roy Abba C. Zubair Hemant S. Murthy Ernesto Ayala Madiha Iqbal Taimur Sher Sikander Ailawadhi Ricardo D. Parrondo Source Type: research
Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm
Bone Marrow Transplantation, Published online: 21 July 2023; doi:10.1038/s41409-023-02042-zHaploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - July 21, 2023 Category: Hematology Authors: Max J. Rieger Sebastian M. Stolz Antonia M. M üller Rahel Schwotzer Gayathri Nair Dominik Schneidawind Markus G. Manz Urs Schanz Source Type: research
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease
Bone Marrow Transplantation, Published online: 20 July 2023; doi:10.1038/s41409-023-02032-1Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - July 20, 2023 Category: Hematology Authors: David Beshensky Filip Pirsl Noa G. Holtzman Seth M. Steinberg Jacqueline W. Mays Edward W. Cowen Leora E. Comis Galen O. Joe M. Teresa Magone Eduard Schulz Meryl A. Waldman Steven Z. Pavletic Source Type: research
